title: Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity.
abstract: Nitric oxide (NO) synthesis is well-known to result from the oxidation of L-arginine by a family of NO synthases (NOS). However, under hypoxic conditions this mechanism of NO synthesis may be impaired and NO is formed by a NOS independent mechanism. This study was designed to examine the reduction of nitrite to NO by xanthine oxidase (XO) under hypoxia, because the bacterial nitrate/nitrite reductases have structural similarity to XO. We found that both purified and tissue containing XO catalyze the reduction of nitrite to NO, as demonstrated using a chemiluminescent NO meter. This redox reaction requires NADH as an electron donor, and is oxygen independent. The inhibitory profiles suggest that reduction of nitrite takes place at the molybdenum center of XO whilst NADH is oxidized at the FAD center. Heparin binding of XO caused an increase in the catalysis of nitrite reduction. The XO-catalyzed generation of NO may be important in redistribution of blood flow to ischaemic tissue as a supplement to NOS, since both nitrite and NADH have been shown to be elevated in hypoxic tissue.
authors.affiliation: Bone and Joint Research Unit, Royal London School of Medicine and Dentistry, United Kingdom. zzhang@nimr.mrc.ac.uk
authors.forename: Z
authors.initials: Z
authors.lastname: Zhang
authors.forename: D
authors.initials: D
authors.lastname: Naughton
authors.forename: P G
authors.initials: PG
authors.lastname: Winyard
authors.forename: N
authors.initials: N
authors.lastname: Benjamin
authors.forename: D R
authors.initials: DR
authors.lastname: Blake
authors.forename: M C
authors.initials: MC
authors.lastname: Symons
mesh_terms: D000693:Anaerobiosis; D000818:Animals; D002417:Cattle; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005182:Flavin-Adenine Dinucleotide / Q000737:chemistry / Q000378:metabolism; D006493:Heparin / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008982:Molybdenum / Q000737:chemistry / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D009572:Nitrite Reductases / Q000737:chemistry / Q000378:metabolism*; D009573:Nitrites / Q000378:metabolism; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism; D013379:Substrate Specificity; D013583:Synovial Membrane / Q000378:metabolism; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D009573:Nitrites; D005182:Flavin-Adenine Dinucleotide; D009569:Nitric Oxide; D008982:Molybdenum; D006493:Heparin; D019001:Nitric Oxide Synthase; D014969:Xanthine Oxidase; D009572:Nitrite Reductases; D010100:Oxygen